91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
how glycomics is joining genomics and proteomics in the study of disease mechanisms and the development of novel therapeutics.
-
.jpg?w=545&itok=qxBSkGrj "IPT discussed in technical publications.")
Michael Phillips and Kevin Rooney discuss .
This article is taken from Innovations in Pharmaceutical Technology Autumn/Winter 2021, pages 39-41. Samedan Ltd
-
, which won the coveted Clinical Research Company of the Year award for having the most successful finalists throughout the competition.
-
Video series: The 3 Cs" of the data journey"
This three part video series examines some of the factors that should be considered to ensure that clinical trial data captured via wearable devices, is monitored expeditiously and effectively.
-
Dr. Johan Du Toit, Executive Director, Internal Medicine, considers strategies from COVID era clinical trials for .
-
Tamie Joeckel discusses .
-
announces that 4D Pharma are working with 91黑料 for an upcoming trial with its lead live biotherapeutic MRx0518 in combination with Merck KGaA’s Bavencio. (a subcription is required to view this article)
-
In this report, Dr Steve Cutler describes 91黑料’s efforts to combat the COVID-19 pandemic and how the crisis has pushed new digital technologies forward
-
Solomon Babani, SVP and General Partner, Biotech and Small/Mid-Size Pharma, contributes to on today’s R&D outsourcing trends across drug development, clinical trial services and manufacturing.
-
This article summarises the companies, including 91黑料, who are backing UNICEF’s drive to supply 2 billion vaccines to the developing world.
.jpg?w=340&itok=2YCoyXLm "IPT discussed in technical publications."){kind=icon}
